Macrophages, Inflammation, and Insulin Resistance
Jerrold M. Olefsky, Christopher K. Glass · Annual Review of Physiology · 2010
Obesity induces an insulin-resistant state in adipose tissue, liver, and muscle and is a strong risk factor for the development of type 2 diabetes mellitus. Insulin resistance in the setting of obesity results from a combination of altered functions of insulin target cells and the accumulation of macrophages that secrete proinflammatory mediators. At the molecular level, insulin resistance is promoted by a transition in macrophage polarization from an alternative M2 activation state maintained by STAT6 and PPARs to a classical M1 activation state driven by NF-kappaB, AP1, and other signal-dependent transcription factors that play crucial roles in innate immunity. Strategies focused on inhibiting the inflammation/insulin resistance axis that otherwise preserve essential innate immune functions may hold promise for therapeutic intervention.
Cited by 2,728 works. doi:10.1146/annurev-physiol-021909-135846
Authors
References
- Defective LPS Signaling in C3H/HeJ and C57BL/10ScCr Mice: Mutations in Tlr4 Gene
- Adipose Expression of Tumor Necrosis Factor-α: Direct Role in Obesity-Linked Insulin Resistance
- The gut microbiota as an environmental factor that regulates fat storage
- Obesity is associated with macrophage accumulation in adipose tissue
- An Antidiabetic Thiazolidinedione Is a High Affinity Ligand for Peroxisome Proliferator-activated Receptor γ (PPARγ)
- The hormone resistin links obesity to diabetes
- Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance
- Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance.
- 15-Deoxy-Δ12,14-Prostaglandin J2 is a ligand for the adipocyte determination factor PPARγ
- Alternative activation of macrophages